Publications list for Professor Tim Lambert

2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008


  • O'Connor, N., Hunt, G., O'Hara-Aarons, M., Hall, A., Snars, J., Storm, V., Lambert, T. (2014), The Sydney Mental Health Client Mortality Audit: what does it tell us and what are we to do?. Australasian Psychiatry. 22(2), 154-159. [Abstract]


  • Lambert, T. (2013), Improving patient adherence in schizophrenia and schizophrenia-related disorders. International Clinical Psychopharmacology. 28 (Suppl 1), S1-S2. [Abstract]
  • Lambert, T. (2013), Practical management of schizophrenia: The role of long-acting Antipsychotics. International Clinical Psychopharmacology. 28, S16-S27. [Abstract]
  • Kalucy, M., Grunstein, R., Lambert, T., Glozier, N. (2013), Obstructive sleep apnoea and schizophrenia - a research agenda. Sleep Medicine Reviews. 17(5), 357-365. [Abstract]
  • Chen, R., Lambert, T. (2013), Managing cardiovascular risk factors in people with serious mental illness: the tragedy of neglect. Endocrinology Today. 2(1), 25-27.
  • Hibbert, E., Lambert, T., Carter, J., Learoyd, D., Twigg, S., Clarke, S. (2013), A randomized controlled pilot trial comparing the impact of access to clinical endocrinology video demonstrations with access to usual revision resources on medical student performance of clinical endocrinology skills. BMC Medical Education. 13, 135. [Abstract]


  • Feiler, G., Chen, R., Pantelis, C., Lambert, T. (2012), Health behaviours of community-treated patients with psychosis. Australasian Psychiatry. 20(3), 208-213. [Abstract]
  • O'Connor, N., Mulley, R., Grasso, B., Lambert, T., Snars, J., Jhita, P. (2012), An Acute Recovery Unit: the first 18 months. Australasian Psychiatry. 20(3), 214-219. [Abstract]
  • Robillard, R., Rogers, N., Whitwell, B., Lambert, T. (2012), Are Cardiometabolic and Endocrine Abnormalities Linked to Sleep Difficulties in Schizophrenia? A Hypothesis Driven Review. Clinical Psychopharmacology and Neuroscience. 10(1), 1-12.
  • Robillard, R., Lambert, T., Rogers, N. (2012), Measuring sleep┬┐wake patterns with physical activity and energy expenditure monitors. Biological Rhythm Research. 43(5), 555-562.
  • Lambert, T., Emmerson, B., Hustig, H., Resseler, S., Jacobs, A., Butcher, B. (2012), Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database. BMC Psychiatry. 12(1), 25. [Abstract]


  • Happell, B., Platania-Phung, C., Gray, R., Hardy, S., Lambert, T., McAllister, M., Davies, C. (2011), A role for mental health nursing in the physical health care of consumers with severe mental illness. Journal of Psychiatric and Mental Health Nursing. 18(8), 706-711. [Abstract]
  • Kelin, K., Lambert, T., Brnabic, A., Newton, R., Ye, W., Escamilla, R., Chen, K., Don, L., Montgomery, W., Karagianis, J., Ascher-Svanum, H. (2011), Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Preference and Adherence. 5, 213-222. [Abstract]
  • Haddad, P., Lambert, T., Lauriello, J. (2011), The role of antipsycholtic long-acting injections in current practice. In: Antipsychotic Long-acting injections. (pp.241-260).United Kingdom: Oxford University Press.
  • Lambert, T., Taylor, D. (2011), Pharmacology of antipsychotic long-acting injections. In: Antipsychotic Long-acting injections. (pp.23-46).United Kingdom: Oxford University Press.
  • Lambert, T. (2011), Prescribing patterns and determinants of use of antipsychotic long-acting injections: an international perspective. In: Antipsychotic Long-acting Injections. (pp.209-230).United Kingdom: Oxford University Press.
  • Lambert, T. (2011), Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber. 34(4), 97-99.
  • Patel, M., Matonhodze, J., Baig, M., Gilleen, J., Boydell, J., Holloway, F., Taylor, D., Szmukler, G., Lambert, T., David, A. (2011), Increased use of antipsychotic long-acting injections with community treatment orders. Therapeutic Advances in Psychopharmacology. 1(2), 37.
  • McGorry, P., Cocks, J., Power, P., Burnett, P., Harrigan, S., Lambert, T. (2011), Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment. Schizophrenia Research and Treatment. 2011, 631690.
  • Dalton, A., Lambert, T., Schrover, R., Hertel, J., Smith, D. (2011), The cost associated with administering risperidone long-acting injections in the Australian community. BMC Health Services Research. 11, 236. [Abstract]
  • Lambert, T., Olivares, J., Peuskens, J., Desouza, C., Kozma, C., Otten, P., Crivera, C., Jacobs, A., Macfadden, W., Mao, L., Rodriguez, S., Dirani, R., Akhras, K. (2011), Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium. Annals of General Psychiatry. 10, 10. [Abstract]


  • Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. (2010), Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders. Biological psychiatry. 67(7), 692-4. [Abstract]
  • Lambert, T. (2010), Disease Management: Multidimensional Approaches to Incomplete Recovery in Psychosis. In: Advances in Biological Psychiatry: Therapy-Resistant Schizophrenia. (pp.87-113).Basel (Switzerland): S. Karger AG,.
  • Lambert, T. (2010), Office for Psychiatric Evaluation and New Media (open). In: The Department of Psychiatry at the University of Melbourne 1964-2009: Personal Reminiscences. (pp.130-134).Australia: University of Melbourne.


  • Lambert, T., Singh, B., Patel, M. (2009), Community treatment orders and antipsychotic long-acting injections. British Journal of Psychiatry. 195(52), S57-S62. [Abstract]
  • Lambert, T. (2009), Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. Evidence - Based Mental Health. 12(2), 50. [Abstract]
  • Lambert, T., Newcomer, J. (2009), Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia. 190(4 Suppl), S39-S42. [Abstract]
  • Lambert, T. (2009), The medical care of people with psychosis. Medical Journal of Australia. 190, 171-172. [Abstract]
  • Addington, J., Lambert, T., Burnett, P. (2009), Complete and incomplete recovery from first-episode psychosis. In: The Recognition and Management of Early Psychosis: A Preventive Approach. (pp.201-222).United Kingdom: Cambridge University Press.


  • Walter, G., Delaroche, A., Soh, N., Hunt, G., Cleary, M., Malhi, G., Lambert, T., Correll, C., Rey, J. (2008), Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 16(4), 253-62. [Abstract]
  • Sundram, S., Lambert, T., Piskulic, D. (2008), Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta psychiatrica Scandinavica. 117(6), 474-478. [Abstract]
  • Lauriello, J., Lambert, T., Andersen, S., Lin, D., Taylor, C., McDonnell, D. (2008), An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. The Journal of clinical psychiatry. 69(5), 790-9. [Abstract]
  • Lambert, T., Norman, T. (2008), Ethnic differences in psychotropic drug response and pharmacokinetics. In: Ethno-psychopharmacology: Advances in Current Practice. (pp.38-61).United Kingdom: Cambridge University Press.